Andrei Braester
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Venous Thromboembolism Diagnosis and Management 38
- Genetics 34
- Chronic Lymphocytic Leukemia Research 26
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Lev Shvidel (25 shared papers)Tamar Tadmor (20 shared papers)Aaron Polliack (18 shared papers)Osnat Bairey (16 shared papers)Yair Herishanu (17 shared papers)Alain Berrébi (9 shared papers)Ohad Benjamini (3 shared papers)Galia Rahav (3 shared papers)
In The Last Decade
Andrei Braester
108 papers receiving 1.7k citations
Andrei Braester's Hit Papers
Peers
Comparison fields: 5 of 73
- Internal Medicine 578
- Genetics 388
- Hematology 170
- Infectious Diseases 217
- Oncology 157
Countries citing papers authored by Andrei Braester
This map shows the geographic impact of Andrei Braester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Braester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Braester more than expected).
Fields of papers citing papers by Andrei Braester
This network shows the impact of papers produced by Andrei Braester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Braester. The network helps show where Andrei Braester may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrei Braester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Hit paper breakdown → | 2023 | 146 |
| 2 | 2021 | 94 | |
| 3 | 2016 | 88 | |
| 4 | 2021 | 86 | |
| 5 | 2003 | 68 | |
| 6 | 2012 | 64 | |
| 7 | 2016 | 57 | |
| 8 | 2016 | 49 | |
| 9 | 2018 | 42 | |
| 10 | 2022 | 40 | |
| 11 | 2022 | 35 | |
| 12 | Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders. | 2006 | 33 |
| 13 | 2013 | 32 | |
| 14 | 2021 | 31 | |
| 15 | 2015 | 28 | |
| 16 | 2021 | 28 | |
| 17 | 2010 | 25 | |
| 18 | 2017 | 25 | |
| 19 | 2018 | 24 | |
| 20 | 2014 | 23 |
About Andrei Braester
Andrei Braester is a scholar working on Internal Medicine, Genetics, Hematology, Biochemistry and Oncology, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (38 papers), Chronic Lymphocytic Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Blood transfusion and management (4 papers), Neutropenia and Cancer Infections (3 papers) and Complement system in diseases (3 papers). The work is most often cited by research in Internal Medicine (578 citations), Genetics (388 citations), Hematology (170 citations), Infectious Diseases (217 citations) and Oncology (157 citations). Andrei Braester has collaborated with scholars based in Israel, Spain and France. Frequent co-authors include Lev Shvidel, Tamar Tadmor, Aaron Polliack, Osnat Bairey, Yair Herishanu, Alain Berrébi, Ohad Benjamini, Galia Rahav, Najib Dally and Luiza Akria. Their work appears in journals such as Blood, Annals of Hematology, The American Journal of Medicine, Thrombosis Research and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.